IN2013MN02451A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN02451A IN2013MN02451A IN2451MUN2013A IN2013MN02451A IN 2013MN02451 A IN2013MN02451 A IN 2013MN02451A IN 2451MUN2013 A IN2451MUN2013 A IN 2451MUN2013A IN 2013MN02451 A IN2013MN02451 A IN 2013MN02451A
- Authority
- IN
- India
- Prior art keywords
- tissue
- standard
- molecule
- relates
- range
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
- G01N2001/2866—Grinding or homogeneising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N2001/2893—Preparing calibration standards
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
The invention relates to a method for preparing a range of dilutions of at least one standard molecule for a tissue according to which use is made of a ground tissue to which the standard molecule is added the whole being conditioned and fractionated before the analysis of a fraction of said tissue. The invention also relates to a method for detecting and quantifying at least one target molecule in at least one tissue using a standard range according to the invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1154731A FR2976076B1 (en) | 2011-05-31 | 2011-05-31 | METHOD FOR DETECTING AND QUANTIFYING TARGET MOLECULE IN TISSUE |
PCT/FR2012/051205 WO2012164221A1 (en) | 2011-05-31 | 2012-05-29 | Method for detecting and quantifying a target molecule in a tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MN02451A true IN2013MN02451A (en) | 2015-04-17 |
Family
ID=46420402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2451MUN2013 IN2013MN02451A (en) | 2011-05-31 | 2012-05-29 |
Country Status (12)
Country | Link |
---|---|
US (1) | US10132796B2 (en) |
EP (1) | EP2715310B1 (en) |
JP (1) | JP6170911B2 (en) |
KR (1) | KR102004350B1 (en) |
CN (1) | CN103688151B (en) |
AU (1) | AU2012264458B2 (en) |
CA (1) | CA2837153C (en) |
DK (1) | DK2715310T3 (en) |
ES (1) | ES2922478T3 (en) |
FR (1) | FR2976076B1 (en) |
IN (1) | IN2013MN02451A (en) |
WO (1) | WO2012164221A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2693037T3 (en) * | 2013-02-25 | 2018-12-07 | Imabiotech | Method to evaluate the selective action of a molecule of interest by a tissue |
CN103336128A (en) * | 2013-06-08 | 2013-10-02 | 天津药物研究院 | Detection method of tissue distribution of small molecule polypeptide drugs |
IL290309B2 (en) * | 2015-11-06 | 2024-04-01 | Ventana Med Syst Inc | Representative diagnostics |
KR101996666B1 (en) * | 2016-05-02 | 2019-07-04 | 주식회사 엘지화학 | Method for quantitative analysis |
EP3805748A4 (en) | 2018-05-30 | 2021-06-23 | Shimadzu Corporation | Spectral data processing device and analysis device |
WO2021168578A1 (en) * | 2020-02-27 | 2021-09-02 | Lsk Technologies Inc. | Systems and methods for characterization of an assay from regions of interest using optical reactions |
WO2021175842A1 (en) | 2020-03-02 | 2021-09-10 | Universiteit Maastricht | Quality control standards for mass spectrometry imaging |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU774575C (en) * | 1999-11-16 | 2005-09-08 | Genentech Inc. | Elisa for VEGF |
EP1550862B1 (en) * | 2002-10-04 | 2012-01-25 | Protosera Inc. | Method of identifying an analyte by gel electrophoresis-mass spectrometry |
US20040096907A1 (en) * | 2002-11-06 | 2004-05-20 | Bernd Bohrmann | Quantification of beta amyloid |
JP2005181011A (en) * | 2003-12-17 | 2005-07-07 | Yoshio Yamauchi | Method of analyzing protein |
JP4547173B2 (en) | 2004-03-17 | 2010-09-22 | シスメックス株式会社 | Diabetes care support system |
WO2007000669A2 (en) | 2005-06-07 | 2007-01-04 | Centre National De La Recherche Scientifique (Cnrs) | Use of conjugates with linkers cleavable by photodissociation or fragmentation for mass spectrometry analysis of tissue sections |
EP2163900A1 (en) | 2008-09-04 | 2010-03-17 | Commissariat A L'energie Atomique | New method of imaging by mass spectrometry and new mass tag associated trityl derivatives |
WO2010041459A1 (en) * | 2008-10-08 | 2010-04-15 | 積水メディカル株式会社 | Method for quantitative analysis of drug metabolite and analyzer |
WO2011073740A1 (en) | 2009-12-15 | 2011-06-23 | Centre National De La Recherche Scientifique (Cnrs) | Matrices for mass spectrometry imaging |
FR2973112B1 (en) | 2011-03-21 | 2018-05-25 | Imabiotech | METHOD FOR DETECTING AND QUANTIFYING TARGET MOLECULE IN A SAMPLE |
EP2767832A1 (en) | 2013-02-18 | 2014-08-20 | Imabiotech | Photo or chemolabile conjugates for molecules detection |
ES2693037T3 (en) | 2013-02-25 | 2018-12-07 | Imabiotech | Method to evaluate the selective action of a molecule of interest by a tissue |
-
2011
- 2011-05-31 FR FR1154731A patent/FR2976076B1/en active Active
-
2012
- 2012-05-29 DK DK12731087.8T patent/DK2715310T3/en active
- 2012-05-29 AU AU2012264458A patent/AU2012264458B2/en active Active
- 2012-05-29 CN CN201280026907.4A patent/CN103688151B/en active Active
- 2012-05-29 ES ES12731087T patent/ES2922478T3/en active Active
- 2012-05-29 EP EP12731087.8A patent/EP2715310B1/en active Active
- 2012-05-29 KR KR1020137035169A patent/KR102004350B1/en active IP Right Grant
- 2012-05-29 CA CA2837153A patent/CA2837153C/en active Active
- 2012-05-29 US US14/123,128 patent/US10132796B2/en active Active
- 2012-05-29 IN IN2451MUN2013 patent/IN2013MN02451A/en unknown
- 2012-05-29 JP JP2014513236A patent/JP6170911B2/en active Active
- 2012-05-29 WO PCT/FR2012/051205 patent/WO2012164221A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2012264458A1 (en) | 2014-01-09 |
FR2976076A1 (en) | 2012-12-07 |
EP2715310B1 (en) | 2022-04-27 |
CN103688151B (en) | 2016-05-18 |
US20140106391A1 (en) | 2014-04-17 |
JP2014520259A (en) | 2014-08-21 |
AU2012264458B2 (en) | 2015-09-24 |
KR20140051187A (en) | 2014-04-30 |
CA2837153C (en) | 2019-06-25 |
WO2012164221A1 (en) | 2012-12-06 |
ES2922478T3 (en) | 2022-09-15 |
US10132796B2 (en) | 2018-11-20 |
DK2715310T3 (en) | 2022-07-25 |
CN103688151A (en) | 2014-03-26 |
CA2837153A1 (en) | 2012-12-06 |
KR102004350B1 (en) | 2019-07-26 |
JP6170911B2 (en) | 2017-07-26 |
FR2976076B1 (en) | 2015-02-27 |
EP2715310A1 (en) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MN02451A (en) | ||
CY1120390T1 (en) | COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES RELATING TO NURSES | |
EP3057620A4 (en) | Methods of using spect/ct analysis for staging cancer | |
AR089993A1 (en) | PEPTIDOMIMETIC MACROCICLES | |
BR112017001579A2 (en) | anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable cd3 antibodies and methods of use | |
EP2715772A4 (en) | Direct sample analysis ion source | |
CO6930363A2 (en) | Benzylindazoles substituted for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases | |
BR112013004012A2 (en) | antibodies to epidermal growth factor receptor 3 (her3). | |
ZA201407051B (en) | Compositions and methods for the collection and isolation of nucleic acids from biological specimens | |
CO7121321A2 (en) | A method and system for multi-energy computerized tomographic analysis of drilling clippings | |
IN2014DN04645A (en) | ||
EP2867656A4 (en) | Cluster analysis of unknowns in sem-eds dataset | |
SG11201401913YA (en) | Systems and methods for biological analysis | |
BR112013013756A2 (en) | multiaxial pedicular fixation set and method of use | |
HK1216760A1 (en) | Fluorescence sensor for target analysis, kit for target analysis, and target analysis method using same | |
SG11201601031QA (en) | Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method | |
BR112013022552A2 (en) | alkyne substituted quinazoline compounds and methods of use | |
IL241496B (en) | Method and system for analyzing biological specimens by spectral imaging | |
SG11201401198PA (en) | Methods for measuring protein content | |
GB201300869D0 (en) | Improvements in or relating to sample analysis | |
IL236132B (en) | Euglobulin-based method for determining the biological activity of defibrotide | |
EP3040724A4 (en) | Method for determining quantity of biological material in tissue section | |
BR112015027841A2 (en) | METHOD FOR MOETTING AND/OR CONDITIONING THE SOIL, CONCENTRATE OF THE SOIL TREATMENT COMPOSITION, AND, USE OF A SOIL TREATMENT COMPOSITION | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
FR2997085B1 (en) | PROCESS FOR PREPARING RETICULATED GEL |